Skip to main content
Top
Published in: Archives of Virology 3/2024

01-03-2024 | Vaccination | Original Article

Foot-and-mouth disease virus strains isolated in Vietnam during 2010-2019: genetic characterization and antigenic relatedness to the Euro SA vaccine

Authors: Ana I. Taffarel, Melanie Y. Barrios Benito, Vo V. Hung, Sabrina Cardillo, Nguyen T. Phuong, Cecilia Caldevilla, Sabrina Galdo Novo

Published in: Archives of Virology | Issue 3/2024

Login to get access

Abstract

Foot-and-mouth disease is a highly contagious disease that affects cloven-hoofed animals. It has an important socio-economic impact on the livestock industry because it produces a drastic decrease of productivity. The disease has been successfully eradicated from some regions, including North America and Western Europe, but it is still endemic in developing countries. Agriculture plays an important role in the national economy of Vietnam, to which animal production contributes a great proportion. The concurrent circulation of foot-and-mouth disease virus (FMDV) serotypes O, A, and Asia 1 has been detected in recent years, but serotype O remains the most prevalent and is responsible for the highest numbers of outbreaks. Appropriate vaccine strain selection is an important element in the control of FMD and is necessary for the application of vaccination programs in FMD-affected regions. Here, we present updated information about the genetic and antigenic characteristics of circulating strains, collected from endemic outbreaks involving types O and A, between 2010 and 2019. Neutralizing assays showed a good in vitro match between type O strains and the monovalent O1 Campos vaccine strain. High r1 values were obtained (above 0.7) when testing a swine serum pool collected 21 days after vaccination, but the O/VTN/2/2019 strain was an exception. An EPP estimation resulted in a median neutralizing titre of about 1.65 log10, indicating that good protection could be achieved. For type A Asia SEA 97 lineage strains, acceptable individual neutralizing titres were obtained with estimated EPP values over 80% for different combinations of vaccine strains. Taking into account that the r1 value is one tool of a battery of tests that should be considered for estimating the cross-protection of a field strain against a vaccine strain, an in vivo challenge experiment was also performed, yielding a PD50 value of 8.0. The results indicate that South American strains could be potentially used for controlling outbreaks involving these lineages. This study demonstrates the importance of considering strain characteristics when choosing vaccine strains and controls.
Literature
2.
go back to reference OIE-FAO (2012). The Global Foot and Mouth Disease Control Strategy. Strengthening Animal Health System through Improved Control of Major Diseases. OIE and FAO editorial, pp43 FAO, Rome, Italy. OIE-FAO (2012). The Global Foot and Mouth Disease Control Strategy. Strengthening Animal Health System through Improved Control of Major Diseases. OIE and FAO editorial, pp43 FAO, Rome, Italy.
4.
go back to reference Fry EE, Lea SM, Jackson T et al (1999) The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J 18(3):543–554CrossRefPubMedPubMedCentral Fry EE, Lea SM, Jackson T et al (1999) The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J 18(3):543–554CrossRefPubMedPubMedCentral
5.
go back to reference Samuel AR, Knowles NJ (2001) Foot-and-mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes). J Gen Virol 82:609–621CrossRefPubMed Samuel AR, Knowles NJ (2001) Foot-and-mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes). J Gen Virol 82:609–621CrossRefPubMed
7.
go back to reference Kitching RP, Knowles NJ, Samuel AR et al (2001) Development of foot and- mouth disease virus strain characterisation–a review. Trop Anim Health Prod 21(3):153–166CrossRef Kitching RP, Knowles NJ, Samuel AR et al (2001) Development of foot and- mouth disease virus strain characterisation–a review. Trop Anim Health Prod 21(3):153–166CrossRef
8.
go back to reference Kitching RP (2005) Global epidemiology and prospects for control of foot-and mouth disease. Curr Top Microbiol Immunol 288:133–148PubMed Kitching RP (2005) Global epidemiology and prospects for control of foot-and mouth disease. Curr Top Microbiol Immunol 288:133–148PubMed
9.
go back to reference Tosh C, Sanyal A, Hemadri D et al (2005) Phylogenetic analysis of serotype A foot-and-mouth disease virus isolated in India between 1977 and 2000. Arch Virol 147(3):493–513CrossRef Tosh C, Sanyal A, Hemadri D et al (2005) Phylogenetic analysis of serotype A foot-and-mouth disease virus isolated in India between 1977 and 2000. Arch Virol 147(3):493–513CrossRef
10.
11.
go back to reference Le VP, Vu TTH, Duong HQ et al (2016) Evolutionary phylodynamics of foot-and-mouth disease virus serotypes O and A circulating in Vietnam. BMC Vet Res 12:269CrossRefPubMedPubMedCentral Le VP, Vu TTH, Duong HQ et al (2016) Evolutionary phylodynamics of foot-and-mouth disease virus serotypes O and A circulating in Vietnam. BMC Vet Res 12:269CrossRefPubMedPubMedCentral
12.
go back to reference Jamal SM, Ferrari G, Ahmed S et al (2011) Molecular characterization of serotype Asia-1 foot-and-mouth disease viruses in Pakistan and Afghanistan; emergence of a new genetic Group and evidence for a novel recombinant virus. Infect Genet Evol 11(8):2049–2062CrossRefPubMed Jamal SM, Ferrari G, Ahmed S et al (2011) Molecular characterization of serotype Asia-1 foot-and-mouth disease viruses in Pakistan and Afghanistan; emergence of a new genetic Group and evidence for a novel recombinant virus. Infect Genet Evol 11(8):2049–2062CrossRefPubMed
13.
go back to reference Kitching P, Hammond J, Jeggo M et al (2007) Global FMD control–is it an option? Vaccine 25(30):5660–5664CrossRefPubMed Kitching P, Hammond J, Jeggo M et al (2007) Global FMD control–is it an option? Vaccine 25(30):5660–5664CrossRefPubMed
14.
go back to reference United Nations (2018) Food and Agriculture Organization of the United Nation, the context of the agriculture and the role of family farms United nations. version i8358EN/1/02.18. United Nations (2018) Food and Agriculture Organization of the United Nation, the context of the agriculture and the role of family farms United nations. version i8358EN/1/02.18.
15.
go back to reference Gleeson LJ (2002) A review of the status of foot and mouth disease in South-East Asia and approaches to control and eradication”. Rev Sci Tech 21(3):465–475CrossRefPubMed Gleeson LJ (2002) A review of the status of foot and mouth disease in South-East Asia and approaches to control and eradication”. Rev Sci Tech 21(3):465–475CrossRefPubMed
16.
go back to reference Le VP, Nguyen T, Lee KN et al (2010) Molecular characterization of serotype A foot-and-mouth disease viruses circulating in Vietnam in 2009. Vet Microbiol 144(1–2):58–66CrossRefPubMed Le VP, Nguyen T, Lee KN et al (2010) Molecular characterization of serotype A foot-and-mouth disease viruses circulating in Vietnam in 2009. Vet Microbiol 144(1–2):58–66CrossRefPubMed
17.
go back to reference Le VP, Nguyen T, Park JH et al (2010) Heterogeneity and genetic variations of serotypes O and Asia 1 foot-and-mouth disease viruses isolated in Vietnam. Vet Microbiol 145(3–4):220–229CrossRefPubMed Le VP, Nguyen T, Park JH et al (2010) Heterogeneity and genetic variations of serotypes O and Asia 1 foot-and-mouth disease viruses isolated in Vietnam. Vet Microbiol 145(3–4):220–229CrossRefPubMed
18.
go back to reference Lee KN, Nguyen T, Kim SM et al (2011) Direct typing and molecular evolutionary analysis of field samples of foot and-mouth disease virus collected in Viet Nam between 2006 and 2007. Vet Microbiol 147(3–4):244–252CrossRefPubMed Lee KN, Nguyen T, Kim SM et al (2011) Direct typing and molecular evolutionary analysis of field samples of foot and-mouth disease virus collected in Viet Nam between 2006 and 2007. Vet Microbiol 147(3–4):244–252CrossRefPubMed
19.
go back to reference Valarcher JF, Knowles NJ, Zakharov V et al (2009) Multiple origins of foot-and mouth disease virus serotype Asia 1 outbreaks, 2003–2007. Emerg Infect Dis 15:1046–1051CrossRefPubMedPubMedCentral Valarcher JF, Knowles NJ, Zakharov V et al (2009) Multiple origins of foot-and mouth disease virus serotype Asia 1 outbreaks, 2003–2007. Emerg Infect Dis 15:1046–1051CrossRefPubMedPubMedCentral
21.
go back to reference Galdo Novo S, Malirat V, Maradei ED et al (2017) Antigenic and immunogenic spectrum of Foot-and- Mouth Disease vaccine strain O 1 Campos against representative viruses of topotypes that circulated in Asia over the past decade. Vaccine 35:1016CrossRef Galdo Novo S, Malirat V, Maradei ED et al (2017) Antigenic and immunogenic spectrum of Foot-and- Mouth Disease vaccine strain O 1 Campos against representative viruses of topotypes that circulated in Asia over the past decade. Vaccine 35:1016CrossRef
22.
go back to reference Galdo Novo S, Malirat V, Maradei E et al (2018) Efficacy of a high quality O1 Campos foot-and-mouth disease vaccine upon challenge with a heterologous Korean O Mya98 lineage virus in pigs. Vaccine 36:15CrossRef Galdo Novo S, Malirat V, Maradei E et al (2018) Efficacy of a high quality O1 Campos foot-and-mouth disease vaccine upon challenge with a heterologous Korean O Mya98 lineage virus in pigs. Vaccine 36:15CrossRef
23.
go back to reference Choi J, Jo HJ, Jung SS, Choi J et al (2021) Evaluation of swine protection with foot-and-mouth disease O 1/Campos and O/Primorsky/2014 vaccines against the O Mya-98 lineage virus from East Asia. Vaccine 39(12):1701–1707CrossRefPubMed Choi J, Jo HJ, Jung SS, Choi J et al (2021) Evaluation of swine protection with foot-and-mouth disease O 1/Campos and O/Primorsky/2014 vaccines against the O Mya-98 lineage virus from East Asia. Vaccine 39(12):1701–1707CrossRefPubMed
24.
go back to reference Maradei E, Malirat V, Perez Beascoechea C et al (2013) Characterization of a type O foot-and-mouth disease virus re-emerging in the year 2011 in free areas of the Southern Cone of South America and cross-protection studies with the vaccine strain in use in the region. Vet Microbiol 162:479–490CrossRefPubMed Maradei E, Malirat V, Perez Beascoechea C et al (2013) Characterization of a type O foot-and-mouth disease virus re-emerging in the year 2011 in free areas of the Southern Cone of South America and cross-protection studies with the vaccine strain in use in the region. Vet Microbiol 162:479–490CrossRefPubMed
25.
go back to reference Malirat V, Franca de Barros JJ, Bergmann IE et al (2007) Phylogenetic analysis of foot-and-mouth disease vírus type O re-remerging in free areas of South America. Virus Res 124:22–28CrossRefPubMed Malirat V, Franca de Barros JJ, Bergmann IE et al (2007) Phylogenetic analysis of foot-and-mouth disease vírus type O re-remerging in free areas of South America. Virus Res 124:22–28CrossRefPubMed
26.
go back to reference Kumar S, Stecher G, Li M et al (2018) MEGA X: molecular evolutionary genetics analysis across computing platforms”. Mol Biol Evol 35:547–1549CrossRef Kumar S, Stecher G, Li M et al (2018) MEGA X: molecular evolutionary genetics analysis across computing platforms”. Mol Biol Evol 35:547–1549CrossRef
27.
go back to reference OIE. World Organisation for Animal Health. Organisation Mondiale de la Santé Animale. (2021) Foot and mouth disease OIE Standards Commission. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 9th ed., (Chapter 3.1.8, page 13). OIE. World Organisation for Animal Health. Organisation Mondiale de la Santé Animale. (2021) Foot and mouth disease OIE Standards Commission. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 9th ed., (Chapter 3.1.8, page 13).
28.
go back to reference PANAFTOSA (Pan-American Foot-and-Mouth Disease Center) (1994) ‘Subproyecto para la correlación de las técnicas de control de potencia de las vacunas contra la Fiebre Aftosa en los países de la Cuenca del Río de la Plata, PANAFTOSA, . PANAFTOSA (Pan-American Foot-and-Mouth Disease Center) (1994) ‘Subproyecto para la correlación de las técnicas de control de potencia de las vacunas contra la Fiebre Aftosa en los países de la Cuenca del Río de la Plata, PANAFTOSA, .
29.
go back to reference European Pharmacopoeia. (2017) Foot-and-mouth disease (ruminants) vaccine (inactivated) Eur. Ph. Vol. 01/2017, 0063. 9th ed. European Pharmacopoeia. (2017) Foot-and-mouth disease (ruminants) vaccine (inactivated) Eur. Ph. Vol. 01/2017, 0063. 9th ed.
30.
go back to reference Darling A, Boose J, Spaltro J (1998) Virus assay methods: accuracy and validation. Biologicals 26:105–110CrossRefPubMed Darling A, Boose J, Spaltro J (1998) Virus assay methods: accuracy and validation. Biologicals 26:105–110CrossRefPubMed
32.
go back to reference Mahapatra M, Upadhyaya S, Aviso S et al (2017) Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007–2012) circulating in Southeast Asia East Asia and Far East. Vaccine 35(51):7147–7153CrossRefPubMedPubMedCentral Mahapatra M, Upadhyaya S, Aviso S et al (2017) Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007–2012) circulating in Southeast Asia East Asia and Far East. Vaccine 35(51):7147–7153CrossRefPubMedPubMedCentral
33.
go back to reference Park M-Y, Han YJ, Choi E-J et al (2021) Post-vaccination monitoring to assess foot-and-mouth disease immunity at population level in Korea. Front Vet Sci 8:673820CrossRefPubMedPubMedCentral Park M-Y, Han YJ, Choi E-J et al (2021) Post-vaccination monitoring to assess foot-and-mouth disease immunity at population level in Korea. Front Vet Sci 8:673820CrossRefPubMedPubMedCentral
35.
go back to reference OIE, FAO (2020) Foot-and-mouth disease reference laboratory network quarterly report 4. OIE World reference laboratory reports OIE, FAO (2020) Foot-and-mouth disease reference laboratory network quarterly report 4. OIE World reference laboratory reports
36.
go back to reference Bergmann I, Malirat V, Pedemonte et al (2021) Challenges in foot-and-mouth disease virus strain selection as an input to attain broad vaccine intraserotype cross-protection. Expert Rev Vacc 10:55 Bergmann I, Malirat V, Pedemonte et al (2021) Challenges in foot-and-mouth disease virus strain selection as an input to attain broad vaccine intraserotype cross-protection. Expert Rev Vacc 10:55
37.
go back to reference Di Giacomo S, Bucafusco D, Barrionuevo F, et al. (2016) Effect of the antigen payload, polyvalence and revaccination in the protection conferred by FMD vacines against heterologous challenge in cattle. Di Giacomo S, Bucafusco D, Barrionuevo F, et al. (2016) Effect of the antigen payload, polyvalence and revaccination in the protection conferred by FMD vacines against heterologous challenge in cattle.
38.
go back to reference Open Session of the European Commision for the Control of Foot-and-Mouth Disease (EUFMD); Oct 26–28Portugal Research Group of the Standing Technical Committee; Cascais. Open Session of the European Commision for the Control of Foot-and-Mouth Disease (EUFMD); Oct 26–28Portugal Research Group of the Standing Technical Committee; Cascais.
39.
go back to reference Bankowska K (2017) FAO world reference laboratory for foot-and-mouth disease (WRLFMD) genotyping report. The Pirbright Institute Bankowska K (2017) FAO world reference laboratory for foot-and-mouth disease (WRLFMD) genotyping report. The Pirbright Institute
40.
go back to reference Hwang J-H, Lee G, Kim A et al (2021) A vaccine strain of the A/ASIA/Sea-97 lineage of foot-and-mouth disease virus with a single amino acid substitution in the P1 region that is adapted to suspension culture provides high immunogenicity. Vaccines 9:308CrossRefPubMedPubMedCentral Hwang J-H, Lee G, Kim A et al (2021) A vaccine strain of the A/ASIA/Sea-97 lineage of foot-and-mouth disease virus with a single amino acid substitution in the P1 region that is adapted to suspension culture provides high immunogenicity. Vaccines 9:308CrossRefPubMedPubMedCentral
41.
go back to reference Chen BJ, Sung WHT, Shieh WK (1999) Managing an animal health emergency inTaipei China: foot and mouth disease. Rev Sci Tech Off Int Epiz 18(1):186–192CrossRef Chen BJ, Sung WHT, Shieh WK (1999) Managing an animal health emergency inTaipei China: foot and mouth disease. Rev Sci Tech Off Int Epiz 18(1):186–192CrossRef
Metadata
Title
Foot-and-mouth disease virus strains isolated in Vietnam during 2010-2019: genetic characterization and antigenic relatedness to the Euro SA vaccine
Authors
Ana I. Taffarel
Melanie Y. Barrios Benito
Vo V. Hung
Sabrina Cardillo
Nguyen T. Phuong
Cecilia Caldevilla
Sabrina Galdo Novo
Publication date
01-03-2024
Publisher
Springer Vienna
Keyword
Vaccination
Published in
Archives of Virology / Issue 3/2024
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-024-05960-5

Other articles of this Issue 3/2024

Archives of Virology 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.